NEWS
Special Reports
All News
FDA Briefs
Oncology Icons
The Targeted Pulse
CONFERENCES
Conference Coverage
Conference Listing
Data Dialogue with the Oncology Brothers
MEDIA
All Videos
Case-Based Peer Perspectives
Evolving Paradigms in Oncology
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Medical World News
Pivotal Practice Views with the Oncology Brothers
Podcasts
Practice Playbook
Shorts
Video Series
Webinars
PUBLICATIONS
All Publications
Evolving Paradigms
Peers & Perspectives in Oncology
Targeted Therapies in Oncology
More
CASE-BASED ROUNDTABLE
PARTNERS
RESOURCES
CME/CE
Clinical Trials
Events
Precision Medicine Perspectives
Press Releases
Sponsored Content
Treatment Resources
SUBSCRIBE
Scout
My Account
Scout
NEWS
CONFERENCES
MEDIA
PUBLICATIONS
CASE-BASED ROUNDTABLE
PARTNERS
RESOURCES
SUBSCRIBE
BRAIN CANCER
BREAST CANCER
HER2 Breast Cancer
COMMUNITY ONCOLOGY PRACTICE
GENITOURINARY CANCERS
Bladder Cancer
Prostate Cancer
Renal Cell Carcinoma
GENOMIC TESTING
Liquid Biopsies
GI CANCERS
Pancreatic Cancer
Colorectal Cancer
Gastric Cancer
GIST
HCC
GYNECOLOGIC CANCERS
Cervical Cancer
Endometrial Cancer
Ovarian Cancer
HEAD & NECK CANCERS
HEMATOLOGY
Bone Marrow & Stem Cell Transplant
IMMUNOTHERAPY
CAR T-Cell Therapy
LEUKEMIAS
AML
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
LUNG CANCER
MET-Targeted Therapy
Small Cell Lung Cancer
Biomarker-Driven Lung Cancer
EGFR+ Lung Cancer
LYMPHOMAS
DLBCL
Follicular Lymphoma
Mantle Cell Lymphoma
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
ONCOLOGY POLICY
SARCOMA
SKIN CANCERS
Melanoma
THYROID CANCERS
Choose Specialty
Spotlight -
Community Oncology Practice
|
Oncology Policy
|
Myeloma
|
CLL
|
Genomic Testing
|
GU Cancers
Advertisement
BTK Inhibition in B-Cell Lymphomas
EP. 1: An Overview of Bruton Tyrosine Kinase Inhibition
June 21st 2019
EP. 2: BTK Inhibitors as Treatment for B-Cell Lymphomas
June 21st 2019
EP. 3: Ibrutinib Therapy in Chronic Lymphocytic Leukemia
June 21st 2019
EP. 4: Other BTK Inhibitors in Chronic Lymphocytic Leukemia
June 21st 2019
EP. 5: BTK Inhibitors in Mantle Cell Lymphoma
June 21st 2019
EP. 6: BTK Inhibitors in Other B-cell Lymphomas
June 21st 2019
EP. 7: Selecting Between Targeted Therapies in B-Cell Lymphomas
June 21st 2019
EP. 8: BTK Inhibitors and Toxicity Management in B-Cell Lymphomas
June 21st 2019
EP. 9: BTK Inhibitors: Infections and Secondary Malignancies
June 21st 2019
EP. 10: Treating With BTK Inhibitors in Practice
June 21st 2019
EP. 11: The Future of BTK Inhibition in B-Cell Lymphomas
June 21st 2019
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Breast Cancer News Roundup: June 2026
2
Ziftomenib Expands Role in Relapsed/Refractory NPM1-Mutated AML
3
Choosing Among Frontline IO/TKI Regimens in Advanced RCC
4
New Considerations Arise in Sequencing After Second Relapse in Multiple Myeloma
5
Lung Cancer News Roundup: June 2026
